BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide — a 15-amino-acid sequence derived from a protein found in human gastric juice. It is one of the most frequently requested tool compounds in preclinical healing and repair research. This overview covers what BPC-157 is, the kinds of studies it appears in, how it differs from TB-500, and how to source a properly documented lot.
Research status. BPC-157 is not an approved drug, and the published evidence is predominantly preclinical (cell and animal models). ChainPep supplies lyophilized BPC-157 acetate for qualified in-vitro laboratory research only, with no human-use or dosing guidance.
What is BPC-157?
BPC-157 is a fragment of human gastric juice protein, synthesized as a stable acetate salt for laboratory use. In research literature it is associated with work on tissue protection and repair signaling, and it has become a common reference compound in programs studying connective-tissue and gastrointestinal healing models. Because much of the public discussion around it is anecdotal, laboratories should rely on peer-reviewed preclinical literature rather than marketing claims when designing studies.
Research themes around BPC-157
- Tendon and ligament models — preclinical studies have examined repair pathways in connective-tissue injury models.
- Gastrointestinal and mucosal protection — reflecting its origin in a gastric protein, BPC-157 appears in gut-healing and mucosal-integrity research.
- Angiogenesis and blood-flow markers — some preclinical programs look at vessel formation and perfusion in repair models.
- Combination studies — BPC-157 is frequently run alongside thymosin beta-4 derived compounds in the same repair programs.
These are research themes, not established clinical effects. Reproducible work depends on correctly identified, high-purity reference material.
BPC-157 vs TB-500
| Attribute | BPC-157 | TB-500 |
|---|---|---|
| Identity | 15-aa fragment of a gastric juice protein | Synthetic fragment of thymosin beta-4 |
| Mechanism studied | Tissue-protection / repair signaling | Actin-sequestering protein; cell-migration and tissue-repair models |
| Common format | Lyophilized acetate vial | Lyophilized acetate vial |
| ChainPep listing | BPC-157 (Acetate) | TB-500 (Thymosin B4 Acetate) |
Researchers who run both as separate arms can also use the BPC-157 + TB-500 blend, while a shorter thymosin beta-4 sequence is available as TB4-FRAG. All belong to the healing and repair research category.
Verifying a BPC-157 lot
Peptide identity is confirmed by mass, not by the label. For every lot, require:
- HPLC purity trace — target peak area-percent with the chromatogram attached, not a generic purity badge.
- ESI-MS identity — observed molecular mass consistent with the theoretical mass of BPC-157 acetate (accounting for the acetate counter-ion convention used on the certificate).
- Appearance and lot number — matching between the Certificate of Analysis and the vial.
ChainPep runs reverse-phase HPLC (UV 214 nm) and ESI-MS positive-mode identity before release; the workflow is described on the testing method page and records render on the Lot Records page by compound.
Storage and handling (laboratory notes)
Keep sealed lyophilized vials frozen near -20°C and protected from light. If a protocol requires reconstitution, use sterile diluent, run it down the inner vial wall and roll gently; do not shake. Refrigerate reconstituted material at 2-8°C and use promptly. ChainPep does not specify concentrations or dosing, which are protocol-level decisions.
Sourcing
Use the verification steps in the buying research peptides guide, inspect the lot record before ordering, and prefer a supplier with research-only terms and tracked, discreet dispatch. The BPC-157 product page lists current box specifications, and laboratories buying across a repair program can request tiered pricing through the wholesale guide.
